WEBULL
WebtradeDownload

Remedy Entertainment (HLSE:REMEDY) Stock Rally Meets Widening Losses And Revenue Drop

Simply Wall St · 2d ago

Remedy Entertainment Oyj went into this earnings day with real momentum. The stock had climbed about 34% over three months and more than 20% in the past month, as investors leaned into the story around CONTROL Resonant. The headline from the quarter lands very differently. Q2 2026 revenue came in at €10.3m and the company reported a net loss of €3.2m with basic earnings per share of €0.24 loss.

The gap between that recent share price strength and a loss-making quarter is now the core question for Remedy shareholders.

Is Remedy Entertainment Oyj a genuine mispriced growth story, or are investors paying up for losses and volatility? Compare the current share price, P/S multiple and DCF gap inside our valuation analysis for Remedy Entertainment Oyj

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs. Q2 2025) €10.31m vs. €16.92m (revenue declined 39%).
  • Net Income / Loss (Q2 2026 vs. Q2 2025) loss of €3.24m vs. loss of €0.57m (loss widened materially).
  • Basic EPS (Q2 2026 vs. Q2 2025) loss of €0.24 per share vs. loss of €0.04 per share (per share loss increased).
  • Operating Cash Flow and Liquidity (Q2 2026) operating cash flow was slightly negative at €0.7m outflow, with cash and short term investments of about €29.6m at quarter end.

Prefer clean charts over another wall of earnings figures and commentary? See how Remedy Entertainment Oyj stacks up in a clear valuation breakdown in the company report for Remedy Entertainment Oyj.

HLSE:REMEDY Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
HLSE:REMEDY Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Remedy bull case hinges on IP momentum and cash

For a bullish view on Remedy Entertainment Oyj, a key support is that the balance sheet still gives meaningful room to execute. Cash and short term investments of about €29.6m help fund CONTROL Resonant marketing and development after a quarter where revenue fell and losses widened. Back catalogue activity around Alan Wake 2 and the original CONTROL, alongside strong wishlists and preorders for CONTROL Resonant that are not yet in reported revenue, supports the thesis that Remedy’s IP can still attract players even in a softer quarter.

Q2 volatility underlines hit driven Remedy risk

On the bearish side, Q2 numbers underline how exposed Remedy Entertainment Oyj is to timing and single title execution. Revenue declined 39% year on year and the loss widened to €3.24m while operating cash flow moved slightly negative. Management links this to FBC: Firebreak timing and heavier CONTROL Resonant marketing. The message is that until CONTROL Resonant launches and converts wishlists and preorders into cash, 2026 profitability is heavily dependent on one release and on flexible marketing spend not eroding that cash buffer.

Compare Remedy Entertainment Oyj’s cash funded IP push with the sharp Q2 revenue drop and widening loss, then ask whether analysts think the current €16.88 share price already reflects that risk and reward. See the consensus price target analysis for Remedy Entertainment Oyj to check how Wall Street expectations line up with this story.

Stay Ahead With Simply Wall St

If the Q2 volatility and cash funded IP push at Remedy Entertainment Oyj has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch how new earnings and game launches affect the story. Once you decide to take a position, use the Portfolio Command Center to cut through noise and get focused updates on fundamental changes that matter to your holdings. For a broader view, lean on the Community to see how other investors are thinking about risks, catalysts and timing. This can help you spot potential inflection points early, understand both upside and downside, and stay ahead of the market.

Seeking Alternatives Beyond Remedy Entertainment?

Fresh ideas move fast. Some stocks are building quiet breakout momentum while they are still under the radar for now. Do not get caught reacting late; act now.

  • Spot companies with strong income potential and balance sheet support before yields get compressed by demand using the curated 440 dividend fortresses.
  • Track early movers in a fast growing corner of technology while prices still reflect limited attention by scanning the focused 57 AI infrastructure stocks.
  • Target businesses positioned around a long term materials story while sentiment is still mixed and entry points may be attractive with the hand picked 28 best rare earth metal stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.